PPD® Biotech is a Phase I-IV contract research organization (CRO) service provider devoted to biotech and small to midsize pharma companies.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
As clinical trial investigators, physicians play an integral role in the development of life-changing medicines.
PPD News and Events Media kit
Accelerated Enrollment Solutions has acquired the clinical research site business of Bioclinica, expanding its global footprint and solidifying AES’ leadership position in patient access and site conduct.
05 Sept. 2019
Harbour BioMed and PPD announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
27 Aug. 2019
Evidera, a business unit of PPD, has entered into an exclusive collaboration agreement with CSS, a subsidiary of SNBL, extending both organizations’ capabilities.
21 Aug. 2019
NeoGenomics and PPD announced the grand opening of a NeoGenomics oncology-focused clinical trials testing lab in the same building as the PPD Laboratories central lab in Singapore.
31 Jul. 2019
Optimal Just-in-Time, a service of PPD’s Accelerated Enrollment Solutions (AES) business unit, and Cancer Treatment Centers of America are collaborating to speed patient enrollment in oncology clinical trials.
16 Jul. 2019
The Synexus HealthyMinds Registry has launched and is seeking 30,000 U.S. participants for a five-year study examining the lifestyle and genetic risk factors impacting cognitive function over time.
09 Jul. 2019
PPD-SNBL has been named a top-five growth business and desirable employer by Randstad Japan.
18 Jun. 2019
Evidera, a business unit of PPD, has entered into an agreement to acquire Medimix International, a global technology company.
30 May 2019
PPD won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions, with 16 PPD clinical research professionals recognized by industry peers for their expertise in the enterprise of drug development.
28 May 2019
PPD has been recognized for excellence in clinical research for the eighth consecutive year by pharmaceutical and biotech executives surveyed for Life Science Leader magazine’s 2019 CRO Leadership Awards.
01 May 2019
Senior Manager, Corporate CommunicationsPPD
Tel: +1 919 456 4425
Manager, Corporate CommunicationsPPD
Tel: +1 919 456 6389
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.